Patents by Inventor Richard Buchta

Richard Buchta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11045479
    Abstract: The present disclosure relates generally to novel molecules, compositions, and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic resistant pathogens.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: June 29, 2021
    Assignee: VYOME THERAPEUTICS LIMITED
    Inventors: Shiladitya Sengupta, Suresh Rameshlal Chawrai, Shamik Ghosh, Sumana Ghosh, Nilu Jain, Suresh Sadhasivam, Richard Buchta, Anamika Bhattacharyya
  • Publication number: 20200163853
    Abstract: Artificial tan removal compositions, methods of preparation and methods of use are provided. The tan removal compositions contain urea and are alkaline in pH. The compositions are effective at removing artificial tan from skin rapidly and in a single application. The compositions are substantially stable over long periods of time.
    Type: Application
    Filed: May 25, 2018
    Publication date: May 28, 2020
    Applicant: BONDI SANDS PTY LTD
    Inventors: Richard BUCHTA, Rose YE, Claire DINH, Robert HOULDEN
  • Publication number: 20190358160
    Abstract: Sub-micron emulsions and processes for their preparation are disclosed. In particular, sub-micron emulsion compositions containing pharmaceutically active ingredients, including delivery vehicles, such as foams, are disclosed. The emulsion compositions and foams may advantageously deliver pharmaceutically active ingredients, such as, for example, corticosteroids. The emulsions maintain stability over extended periods of time.
    Type: Application
    Filed: May 9, 2019
    Publication date: November 28, 2019
    Applicant: Formulytica Pty Ltd
    Inventors: Richard Buchta, Robert Houlden, Biljana Roughan, Sasaros Anuvechsirikiat
  • Publication number: 20180318313
    Abstract: The present disclosure relates generally to novel molecules, compositions, and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic resistant pathogens.
    Type: Application
    Filed: July 18, 2018
    Publication date: November 8, 2018
    Applicant: VYOME BIOSCIENCES PVT. LTD.
    Inventors: Shiladitya SENGUPTA, Suresh Rameshlal CHAWRAI, Shamik GHOSH, Sumana GHOSH, Nilu JAIN, Suresh SADHASIVAM, Richard BUCHTA, Anamika BHATTACHARYYA
  • Patent number: 10071103
    Abstract: The present disclosure relates generally to novel molecules, compositions, and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic resistant pathogens.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: September 11, 2018
    Assignee: VYOME BIOSCIENNCES PVT. LTD.
    Inventors: Shiladitya Sengupta, Suresh Rameshlal Chawrai, Shamik Ghosh, Sumana Ghosh, Nilu Jain, Suresh Sadhasivam, Richard Buchta, Anamika Bhattacharyya
  • Publication number: 20160346294
    Abstract: The present disclosure relates generally to novel molecules, compositions, and formulations for treatment of bacterial infections in general and more specifically to bacterial infections with antibiotic resistant pathogens
    Type: Application
    Filed: January 29, 2015
    Publication date: December 1, 2016
    Applicant: VYOME BIOSCIENCES PVT. LTD.
    Inventors: Shiladitya SENGUPTA, Suresh Rameshlal CHAWRAI, Shamik GHOSH, Sumana GHOSH, Nilu JAIN, Suresh SADHASIVAM, Richard BUCHTA, Anamika BHATTACHARYYA
  • Patent number: 8629128
    Abstract: A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof; an occlusive agent; an aqueous solvent; an organic cosolvent; wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent; and the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use. In a second embodiment, an oil-in water emulsion having a vitamin, an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.
    Type: Grant
    Filed: September 20, 2012
    Date of Patent: January 14, 2014
    Assignee: Stiefel West Coast, LLC
    Inventors: Richard Buchta, Robert James Houlden, Maria Graziella Larm, Leon Loupenok, Rose Ye
  • Publication number: 20130101525
    Abstract: A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof; an occlusive agent; an aqueous solvent; an organic cosolvent; wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent; and the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use. In a second embodiment, an oil-in water emulsion having a vitamin, an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.
    Type: Application
    Filed: September 20, 2012
    Publication date: April 25, 2013
    Applicant: STIEFEL RESEARCH AUSTRALIA PTY LTD
    Inventors: Richard BUCHTA, Robert James HOULDEN, Maria Graziella LARM, Leon LOUPENOK, Rose YE
  • Patent number: 8298515
    Abstract: A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof; an occlusive agent; an aqueous solvent; an organic cosolvent; wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent; and the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use. In a second embodiment, an oil-in water emulsion having a vitamin, an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.
    Type: Grant
    Filed: September 28, 2010
    Date of Patent: October 30, 2012
    Assignee: Stiefel Research Australia Pty Ltd.
    Inventors: Richard Buchta, Robert James Houlden, Maria Graziella Larm, Leon Loupenok, Rose Ye
  • Patent number: 8263580
    Abstract: A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof; an occlusive agent; an aqueous solvent; an organic cosolvent; wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent; and the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use. In a second embodiment, an oil-in water emulsion having a vitamin, an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.
    Type: Grant
    Filed: May 26, 2006
    Date of Patent: September 11, 2012
    Assignee: Stiefel Research Australia Pty Ltd
    Inventors: Richard Buchta, Robert James Houlden, Rose Ye, Maria Graziella Larm, Leon Loupenok
  • Publication number: 20110014135
    Abstract: A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof; an occlusive agent; an aqueous solvent; an organic cosolvent; wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent; and the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use. In a second embodiment, an oil-in water emulsion having a vitamin, an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.
    Type: Application
    Filed: September 28, 2010
    Publication date: January 20, 2011
    Applicant: STIEFEL RESEARCH AUSTRALIA PTY LTD
    Inventors: Richard BUCHTA, Robert HOULDEN, Rose YE, Maria LARM, Leon LOUPENOK
  • Publication number: 20060292080
    Abstract: A pharmaceutical aerosol foam composition, comprising: an effective amount of a pharmaceutically active ingredient, wherein said pharmaceutically active ingredient is a vitamin or analogue thereof; an occlusive agent; an aqueous solvent; an organic cosolvent; wherein the pharmaceutically active ingredient is insoluble in both water and the occlusive agent; and the occlusive agent being present in an amount sufficient to form an occlusive layer on the skin, in use. In a second embodiment, an oil-in water emulsion having a vitamin, an occlusive agent; an aqueous solvent; and an organic cosolvent, wherein the occlusive agent is present in an amount sufficient to form an occlusive layer on the skin.
    Type: Application
    Filed: May 26, 2006
    Publication date: December 28, 2006
    Applicant: Connetics Australia Pty Ltd
    Inventors: Alby Abram, Richard Buchta, Robert Houlden, Rose Ye
  • Patent number: 6524592
    Abstract: The invention relates to vaccines which are suitable for the prevention of clostridial diseases of sheep (and lambs), providing an effective immunity for up to a year or more following a single injection or dose.
    Type: Grant
    Filed: May 23, 2000
    Date of Patent: February 25, 2003
    Assignee: American Home Products Corporation
    Inventors: Richard Buchta, Christopher Leigh Schwartzkoff, Philip Ralph Lehrbach
  • Publication number: 20020098204
    Abstract: The invention relates to vaccines which are suitable for the prevention of clostridial diseases of sheep (and lambs), providing an effective immunity for up to a year or more following a single injection or dose.
    Type: Application
    Filed: May 23, 2000
    Publication date: July 25, 2002
    Applicant: AMERICAN HOME PRODUCTS CORPORATION
    Inventors: RICHARD BUCHTA, CHRISTOPHER LEIGH SCHWARTZKOFF, PHILIP RALPH LEHRBACH